ACT Capital Management’s Leap Therapeutics LPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $233K | Hold |
26,500
| – | – | 0.32% | 37 |
|
|
2022
Q2 | $305K | Hold |
26,500
| – | – | 0.43% | 34 |
|
|
2022
Q1 | $464K | Buy |
26,500
+4,000
| +18% | +$70K | 0.49% | 35 |
|
|
2021
Q4 | $729K | Buy |
22,500
+7,000
| +45% | +$227K | 0.53% | 36 |
|
|
2021
Q3 | $622K | Buy |
15,500
+2,100
| +16% | +$84.3K | 0.32% | 53 |
|
|
2021
Q2 | $220K | Buy |
+13,400
| New | +$220K | 0.11% | 85 |
|